| 21 |
Schrimpf C, Duffield JS. Mechanisms of fibrosis: the role of the pericyte [J]. Curr Opin Nephrol Hypertens, 2011, 20(3): 297-305.
|
| 22 |
Humphreys BD, Lin SL, Kobayashi A, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis [J]. Am J Pathol, 2010, 176(1): 85-97.
|
| 23 |
Schrimpf C, Xin C, Campanholle G, et al. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury [J]. J Am Soc Nephrol, 2012, 23(5): 868-883.
|
| 24 |
Lin SL, Chang FC, Schrimpf C, et al. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis [J]. Am J Pathol, 2011, 178(2): 911-923.
|
| 25 |
Linkermann A, Bräsen JH, Darding M, et al. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury [J]. Proc Natl Acad Sci USA, 2013, 110(29): 12024-12029.
|
| 26 |
Linkermann A, De Zen F, Weinberg J, et al. Programmed necrosis in acute kidney injury [J]. Nephrol Dial Transplant, 2012, 27(9): 3412-3419.
|
| 27 |
Cianciolo Cosentino C, Skrypnyk NI, Brilli LL, et al. Histone deacetylase inhibitor enhances recovery after AKI [J]. J Am Soc Nephrol, 2013, 24(6): 943-953.
|
| 28 |
Zhou L, Fu P, Huang XR, et al. Activation of p53 promotes renal injury in acute aristolochic acid nephropathy [J]. J Am Soc Nephrol, 2010, 21(1): 31-41.
|
| 29 |
Linfert D, Chowdhry T, Rabb H. Lymphocytes and ischemia-reperfusion injury [J]. Transplant Rev (Orlando), 2009, 23(1): 1-10.
|
| 30 |
Kinsey GR, Sharma R, Huang L, et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury [J]. J Am Soc Nephrol, 2009, 20(8): 1744-1753.
|
| 31 |
Burne-Taney MJ, Ascon DB, Daniels F, et al. B cell deficiency confers protection from renal ischemia reperfusion injury [J]. J Immunol, 2003, 171(6): 3210-3215.
|
| 32 |
Park P, Haas M, Cunningham PN, et al. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes [J]. Am J Physiol Renal Physiol, 2002, 282(2): F352-F357.
|
| 33 |
Ysebaert DK, De Greef KE, Vercauteren SR, et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury [J]. Nephrol Dial Transplant, 2000, 15(10): 1562-1574.
|
| 34 |
Savill J, Smith J, Sarraf C, et al. Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis [J]. Kidney Int, 1992, 42(4): 924-936.
|
| 35 |
Day YJ, Huang L, Ye H, et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages [J]. Am J Physiol Renal Physiol, 2005, 288(4): F722-F731.
|
| 36 |
Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair [J]. J Clin Invest, 2008, 118(11): 3522-3530.
|
| 37 |
Lin SL, Li B, Rao S, et al. Macrophage Wnt7b is critical for kidney repair and regeneration [J]. Proc Natl Acad Sci USA, 2010, 107(9): 4194-4199.
|
| 38 |
Kim MG, Kim SC, Ko YS, et al. The role of M2 macrophages in the progression of chronic kidney disease following acute kidney injury [J]. PLoS One, 2015, 10(12): e0143961.
|
| 39 |
Jang HS, Kim J, Park YK, et al. Infiltrated macrophages contribute to recovery after ischemic injury but not to ischemic preconditioning in kidneys [J]. Transplantation, 2008, 85(3): 447-455.
|
| 40 |
Lech M, Rommele C, Grobmayr R, et al. Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury [J]. Kidney Int, 2013, 83(4): 647-661.
|
| 41 |
Lee S, Huen S, Nishio H, et al. Distinct macrophage phenotypes contribute to kidney injury and repair [J]. J Am Soc Nephrol, 2011, 22(2): 317-326.
|
| 42 |
Lech M, Grobmayr R, Ryu M, et al. Macrophage phenotype controls long-term AKI outcomes-kidney regeneration versus atrophy [J]. J Am Soc Nephrol, 2014, 25(2): 292-304.
|
| 43 |
Kumar S, Liu J, McMahon AP. Defining the acute kidney injury and repair transcriptome [J]. Semin Nephrol, 2014, 34(4): 404-417.
|
| 44 |
Basile DP, Fredrich K, Alausa M, et al. Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure [J]. Am J Physiol Renal Physiol, 2005, 288(5): F953-F963.
|
| 45 |
Basile DP, Martin DR, Hammerman MR. Extracellular matrix-related genes in kidney after ischemic injury: potential role for TGF-beta in repair [J]. Am J Physiol, 1998, 275(6 Pt 2): F894-F903.
|
| 46 |
Stroo I, Stokman G, Teske GJ, et al. Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase [J]. Int Immunol, 2010, 22(6): 433-442.
|
| 47 |
Havasi A, Haegele JA, Gall JM, et al. Histone acetyl transferase (HAT) HBO1 and JADE1 in epithelial cell regeneration [J]. Am J Pathol, 2013, 182(1): 152-162.
|
| 48 |
Nangaku M, Hirakawa Y, Mimura I, et al. Epigenetic changes in the acute kidney injury-to-chronic kidney disease transition [J]. Nephron, 2017, [Epub ahead of print]．
|
| 49 |
Bomsztyk K, Flanagin S, Mar D, et al. Synchronous recruitment of epigenetic modifiers to endotoxin synergistically activated Tnf-α gene in acute kidney injury [J]. PLoS One, 2013, 8(7): e70322.
|
| 50 |
Lorenzen JM, Kaucsar T, Schauerte C, et al. MicroRNA-24 antagonism prevents renal ischemia reperfusion injury [J]. J Am Soc Nephrol, 2014, 25(12): 2717-2729.
|
| 1 |
James M, Bouchard J, Ho J, et al. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury [J]. Am J Kidney Dis, 2013, 61(5): 673-685.
|
| 2 |
Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup [J]. Nat Rev Nephrol, 2017, 13(4): 241-257.
|
| 3 |
Forni LG, Darmon M, Ostermann M, et al. Renal recovery after acute kidney injury [J]. Intensive Care Med, 2017, 43(6): 855-866.
|
| 51 |
Wei Q, Bhatt K, He HZ, et al. Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury [J]. J Am Soc Nephrol, 2010, 21(5): 756-761.
|
| 52 |
Cantaluppi V, Gatti S, Medica D, et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells [J]. Kidney Int, 2012, 82(4): 412-427.
|
| 53 |
Ko GJ, Grigoryev DN, Linfert D, et al. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition [J]. Am J Physiol Renal Physiol, 2010, 298(6): F1472-F1483.
|
| 4 |
Heung M, Steffick DE, Zivin K, et al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of veterans health administration data [J]. Am J Kidney Dis, 2016, 67(5): 742-752.
|
| 5 |
Nie S, Feng Z, Xia L, et al. Risk factors of prognosis after acute kidney injury in hospitalized patients [J]. Front Med, 2017, 11(3): 393-402.
|
| 6 |
Wald R, Shariff SZ, Adhikari NK, et al. The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study [J]. Crit Care Med, 2014, 42(4): 868-877.
|
| 54 |
Yang YH, He XJ, Chen SR, et al. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study [J]. Endocrine, 2009, 36(1): 45-51.
|
| 55 |
Lin YF, Ko WJ, Chu TS, et al. The 90-day mortality and the subsequent renal recovery in critically ill surgical patients requiring acute renal replacement therapy [J]. Am J Surg, 2009, 198(3): 325-332.
|
| 56 |
Rajagopalan R, Neumann WL, Poreddy AR, et al. Hydrophilic pyrazine dyes as exogenous fluorescent tracer agents for real-time point-of-care measurement of glomerular filtration rate [J]. J Med Chem, 2011, 54(14): 5048-5058.
|
| 7 |
Bouchard J, Acharya A, Cerda J, et al. A prospective international multicenter study of AKI in the intensive care unit [J]. Clin J Am Soc Nephrol, 2015, 10(8): 1324-1331.
|
| 8 |
Bell M, Granath F, Schön S, et al. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure [J]. Intensive Care Med, 2007, 33(5): 773-780.
|
| 9 |
Truche AS, Darmon M, Bailly S, et al. Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery [J]. Intensive Care Med, 2016, 42(9): 1408-1417.
|
| 57 |
Neyra JA, Manllo J, Li X, et al. Association of de novo dipstick albuminuria with severe acute kidney injury in critically ill septic patients [J]. Nephron Clin Pract, 2014, 128(3-4): 373-380.
|
| 58 |
Srisawat N, Murugan R, Kellum JA. Repair or progression after AKI: a role for biomarkers? [J]. Nephron Clin Pract, 2014, 127(1-4): 185-189.
|
| 59 |
Lopez-Otin C, Blasco MA, Partridge L, et al. The hallmarks of aging [J]. Cell, 2013, 153(6): 1194-1217.
|
| 10 |
Palant CE, Amdur RL, Chawla LS. The acute kidney injury to chronic kidney disease transition: a potential opportunity to improve care in acute kidney injury [J]. Contrib Nephrol, 2016, 187: 55-72.
|
| 11 |
Ferenbach DA, Bonventre JV. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD [J]. Nat Rev Nephrol, 2015, 11(5): 264-276.
|
| 12 |
Evans RG, Ince C, Joles JA, et al. Haemodynamic influences on kidney oxygenation: clinical implications of integrative physiology [J]. Clin Exp Pharmacol Physiol, 2013, 40(2): 106-122.
|
| 60 |
Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence [J]. Ann N Y Acad Sci, 2000, 908: 244-254.
|
| 61 |
Reutzel-Selke A, Jurisch A, Denecke C, et al. Donor age intensifies the early immune response after transplantation [J]. Kidney Int, 2007, 71(7): 629-636.
|
| 62 |
Kelly J, Ali Khan A, Yin J, et al. Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice [J]. J Clin Invest, 2007, 117(11): 3421-3426.
|
| 13 |
Noiri E, Nakao A, Uchida K, et al. Oxidative and nitrosative stress in acute renal ischemia [J]. Am J Physiol Renal Physiol, 2001, 281(5): F948-F957.
|
| 14 |
De Greef KE, Ysebaert DK, Persy V, et al. ICAM-1 expression and leukocyte accumulation in inner stripe of outer medulla in early phase of ischemic compared to HgCl2-induced ARF [J]. Kidney Int, 2003, 63(5): 1697-1707.
|
| 15 |
Kelly KJ, Sutton TA, Weathered N, et al. Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury [J]. Am J Physiol Renal Physiol, 2004, 287(4): F760-F766.
|
| 16 |
Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function [J]. Kidney Int, 2007, 72(2): 151-156.
|
| 17 |
Kim M, Ham A, Kim JY, et al. The volatile anesthetic isoflurane induces ecto-5′-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury [J]. Kidney Int, 2013, 84(1): 90-103.
|
| 18 |
Venkatachalam MA, Weinberg JM. The conundrum of protection from AKI by adenosine in rodent clamp ischemia models [J]. Kidney Int, 2013, 84(1): 16-19.
|
| 63 |
Kwekel JC, Desai VG, Moland CL, et al. Life cycle analysis of kidney gene expression in male F344 rats [J]. PLoS One, 2013, 8(10): e75305.
|
| 64 |
Kuilman T, Michaloglou C, Mooi WJ, et al. The essence of senescence [J]. Genes Dev, 2010, 24(22): 2463-2479.
|
| 65 |
Schmitt R, Marlier A, Cantley LG. Zag expression during aging suppresses proliferation after kidney injury [J]. J Am Soc Nephrol, 2008, 19(12): 2375-2383.
|
| 19 |
Geng H, Lan R, Wang G, et al. Inhibition of autoregulated TGFbeta signaling simultaneously enhances proliferation and differentiation of kidney epithelium and promotes repair following renal ischemia [J]. Am J Pathol, 2009, 174(4): 1291-1308.
|
| 20 |
Spurgeon KR, Donohoe DL, Basile DP. Transforming growth factor-beta in acute renal failure: receptor expression, effects on proliferation, cellularity, and vascularization after recovery from injury [J]. Am J Physiol Renal Physiol, 2005, 288(3): F568-F577.
|
| 66 |
Karam Z, Tuazon J. Anatomic and physiologic changes of the aging kidney [J]. Clin Geriatr Med, 2013, 29(3): 555-564.
|
| 67 |
Thum T, Hoeber S, Froese S, et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1 [J]. Circ Res, 2007, 100(3): 434-443.
|
| 68 |
Behrens A, van Deursen JM, Rudolph KL, et al. Impact of genomic damage and ageing on stem cell function [J]. Nat Cell Biol, 2014, 16(3): 201-207.
|
| 69 |
Stolzing A, Scutt A. Age-related impairment of mesenchymal progenitor cell function [J]. Aging Cell, 2006, 5(3): 213-224.
|